Fjarde Ap-fonden’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $73.9M | Sell |
148,682
-1,280
| -0.9% | -$567K | 0.35% | 55 |
|
|
2026
Q1 | $67M | Buy |
149,962
+60,900
| +68% | +$28.4M | 0.37% | 52 |
|
|
2025
Q4 | $40.4M | Sell |
89,062
-560
| -0.6% | -$241K | 0.34% | 62 |
|
|
2025
Q3 | $35.1M | Sell |
89,622
-1,466
| -2% | -$613K | 0.3% | 69 |
|
|
2025
Q2 | $40.6M | Buy |
91,088
+17,200
| +23% | +$7.93M | 0.37% | 53 |
|
|
2025
Q1 | $35.8M | Buy |
73,888
+5,800
| +9% | +$2.7M | 0.43% | 43 |
|
|
2024
Q4 | $27.4M | Sell |
68,088
-3,900
| -5% | -$1.81M | 0.28% | 67 |
|
|
2024
Q3 | $33.5M | Buy |
+71,988
| New | +$34.6M | 0.34% | 52 |
|
|
2024
Q1 | $29.7M | Buy |
70,988
+2,000
| +3% | +$845K | 0.33% | 57 |
|
|
2023
Q4 | $28.1M | Sell |
68,988
-2,500
| -3% | -$924K | 0.35% | 51 |
|
|
2023
Q3 | $24.9M | Sell |
71,488
-1,200
| -2% | -$420K | 0.33% | 55 |
|
|
2023
Q2 | $25.6M | Buy |
72,688
+6,700
| +10% | +$2.26M | 0.31% | 59 |
|
|
2023
Q1 | $20.8M | Sell |
65,988
-900
| -1% | -$270K | 0.28% | 79 |
|
|
2022
Q4 | $19.3M | Sell |
66,888
-34,898
| -34% | -$10.6M | 0.27% | 81 |
|
|
2022
Q3 | $28.7M | Hold |
101,786
| – | – | 0.36% | 54 |
|
|
2022
Q2 | $28.7M | Buy |
101,786
+31,700
| +45% | +$8.48M | 0.36% | 54 |
|
|
2022
Q1 | $18.3M | Sell |
70,086
-401
| -0.6% | -$95.2K | 0.18% | 109 |
|
|
2021
Q4 | $15.5M | Sell |
70,487
-700
| -1% | -$136K | 0.14% | 142 |
|
|
2021
Q3 | $12.9M | Sell |
71,187
-548
| -0.8% | -$107K | 0.12% | 164 |
|
|
2021
Q2 | $14.5M | Sell |
71,735
-5,600
| -7% | -$1.17M | 0.13% | 153 |
|
|
2021
Q1 | $16.6M | Buy |
77,335
+300
| +0.4% | +$65.9K | 0.15% | 134 |
|
|
2020
Q4 | $18.2M | Sell |
77,035
-2,300
| -3% | -$528K | 0.17% | 120 |
|
|
2020
Q3 | $21.6M | Buy |
79,335
+5,300
| +7% | +$1.46M | 0.24% | 84 |
|
|
2020
Q2 | $21.5M | Buy |
74,035
+4,342
| +6% | +$1.18M | 0.27% | 72 |
|
|
2020
Q1 | $16.6M | Sell |
69,693
-300
| -0.4% | -$68.8K | 0.27% | 74 |
|
|
2019
Q4 | $15.3M | Buy |
69,993
+4,400
| +7% | +$890K | 0.19% | 115 |
|
|
2019
Q3 | $11.1M | Buy |
65,593
+1,400
| +2% | +$248K | 0.14% | 164 |
|
|
2019
Q2 | $11.8M | Sell |
64,193
-7,500
| -10% | -$1.31M | 0.15% | 151 |
|
|
2019
Q1 | $13.2M | Buy |
71,693
+12,033
| +20% | +$2.22M | 0.17% | 127 |
|
|
2018
Q4 | $9.89M | Sell |
59,660
-7,700
| -11% | -$1.33M | 0.17% | 124 |
|
|
2018
Q3 | $13M | Sell |
67,360
-2,902
| -4% | -$517K | 0.19% | 115 |
|
|
2018
Q2 | $11.9M | Buy |
70,262
+254
| +0.4% | +$39.4K | 0.18% | 123 |
|
|
2018
Q1 | $11.4M | Buy |
70,008
+744
| +1% | +$122K | 0.17% | 129 |
|
|
2017
Q4 | $10.4M | Buy |
69,264
+10,892
| +19% | +$1.61M | 0.16% | 142 |
|
|
2017
Q3 | $8.88M | Buy |
58,372
+1,122
| +2% | +$169K | 0.17% | 135 |
|
|
2017
Q2 | $7.38M | Buy |
57,250
+6,788
| +13% | +$817K | 0.15% | 153 |
|
|
2017
Q1 | $5.52M | Sell |
50,462
-2,962
| -6% | -$261K | 0.13% | 173 |
|
|
2016
Q4 | $3.94M | Sell |
53,424
-5,445
| -9% | -$443K | 0.09% | 248 |
|
|
2016
Q3 | $5.13M | Buy |
58,869
+1,508
| +3% | +$143K | 0.11% | 210 |
|
|
2016
Q2 | $4.93M | Buy |
57,361
+1,438
| +3% | +$124K | 0.11% | 206 |
|
|
2016
Q1 | $4.45M | Buy |
55,923
+7,338
| +15% | +$664K | 0.1% | 221 |
|
|
2015
Q4 | $6.11M | Buy |
48,585
+1,127
| +2% | +$136K | 0.16% | 143 |
|
|
2015
Q3 | $4.94M | Sell |
47,458
-3,459
| -7% | -$444K | 0.14% | 171 |
|
|
2015
Q2 | $6.29M | Sell |
50,917
-3,267
| -6% | -$412K | 0.15% | 156 |
|
|
2015
Q1 | $6.39M | Sell |
54,184
-2,204
| -4% | -$264K | 0.15% | 163 |
|
|
2014
Q4 | $6.7M | Sell |
56,388
-4,606
| -8% | -$519K | 0.15% | 163 |
|
|
2014
Q3 | $6.85M | Sell |
60,994
-5,223
| -8% | -$497K | 0.15% | 156 |
|
|
2014
Q2 | $6.27M | Sell |
66,217
-1,138
| -2% | -$79.8K | 0.12% | 184 |
|
|
2014
Q1 | $4.76M | Buy |
67,355
+2,396
| +4% | +$190K | 0.09% | 242 |
|
|
2013
Q4 | $4.83M | Sell |
64,959
-404
| -0.6% | -$28.1K | 0.1% | 221 |
|
|
2013
Q3 | $4.96M | Sell |
65,363
-19,014
| -23% | -$1.51M | 0.11% | 215 |
|
|
2013
Q2 | $6.74M | Buy |
+84,377
| New | +$6.21M | 0.14% | 159 |
|
Other funds holding VRTX
Fjarde Ap-fonden's VRTX Position: Q2 2026 in Review
Fjarde Ap-fonden reduced its Vertex Pharmaceuticals (VRTX) stake by 0.85% in Q2 2026, selling an estimated $567K and leaving 148,682 shares worth $73.9M. The position accounts for 0.35% of the portfolio, ranked #55.
Fjarde Ap-fonden first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Fjarde Ap-fonden held 148,682 shares of Vertex Pharmaceuticals worth $73.9M as of Q2 2026.
- Fjarde Ap-fonden sold 1,280 Vertex Pharmaceuticals shares in Q2 2026, an estimated $567K.
- Vertex Pharmaceuticals made up 0.35% of Fjarde Ap-fonden's portfolio in Q2 2026, its #55 holding.
- Fjarde Ap-fonden first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.